It is well known that in cancer, the TGF-β1/TGF-β1 receptor complex controls various downstream signaling pathways, including Akt and MAPK signal transduction pathways, as well as the canonical SMAD dependent pathway [22]. The gene discussed is AKT1; the disease is cancer.